Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 7, 2019 - Pfizer announced the discontinuation of Embeda (morphine/naltrexone) extended-release capsules due to business reasons.
Download PDF
Return to publications
